• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FT3 III; RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FT3 III; RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE Back to Search Results
Model Number FT3 G3
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/03/2022
Type of Reportable Event Malfunction
Event or Problem Description
There was an allegation of questionable elecsys ft3 iii results for 1 patient sample on a cobas e 801 module compared to another e801 module, an e411 module, and an abbott architect.It is not known if any questionable results were reported outside of the laboratory.The customer's e801 module serial number was requested but not provided.The investigational e401 module's serial number is (b)(4).The ft3 reagent lot used was 585947.The investigational e801 module's serial number is (b)(4).The ft3 reagent lot used was 583301 and the expiration date is 28-feb-2023.This medwatch will cover ft3 iii.Refer to medwatch with patient identifier (b)(6) for information on the ft4 iii results and a1 patient identifier (b)(6) for information on the ft3 iii ver.2 results.
 
Additional Manufacturer Narrative
The investigation is ongoing.
 
Additional Manufacturer Narrative
The investigation found that there was sample interference with the streptavidin component of the reagent.Product labeling states, "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur." the discrepancies in the different ft3 reagent versions are consistent with the different physical reaction conditions of the ft3 assay and the effect of the interfering factor.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FT3 III
Common Device Name
RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key15694502
Report Number1823260-2022-03408
Device Sequence Number15153689
Product Code CDP
UDI-Device Identifier04015630939718
UDI-Public04015630939718
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K963127
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/13/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2023
Device Model NumberFT3 G3
Device Catalogue Number07027362190
Device Lot Number585947, 583301
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/05/2022
Supplement Date Received by Manufacturer12/21/2022
Initial Report FDA Received Date10/29/2022
Supplement Report FDA Received Date01/13/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-